{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:44:32Z","timestamp":1786581872322,"version":"build-2736575974"},"reference-count":25,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>HIV-infected women are at increased risk for cervical dysplasia and require timely follow-up after an abnormal Papanicolaou (Pap) test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective cohort study assessed the proportion of HIV-infected women with colposcopic evaluation after an abnormal Pap test. Time to colposcopy within 12 months after an abnormal Pap test was assessed with univariate and multivariate Cox proportional hazard modeling in a diverse cohort of HIV-infected women between October 1, 2003, and September 30, 2007.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred seventy-seven subjects had an abnormal Pap test: 22 high-grade intraepithelial lesion (HSIL; 12%), 120 low-grade squamous intraepithelial lesion (LSIL; 68%), and 35 atypical squamous cells of undetermined significance, human papillomavirus positive (20%). One hundred twenty (68%) had follow-up colposcopy by 1 year. Decreased time to follow-up was associated with being married (HR 3.5, 95% CI 1.9\u20136.2), high school graduate or higher education level (HR 1.7, CI 1.2\u20132.6), HSIL Pap results (HR 2.8, CI 1.3\u20136.2), Pap testing performed by HIV nurse practitioner versus gynecology clinic (HR 1.7, 1.1\u20132.7), and CD4 count \u2265500 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      (HR 1.8, CI 1.2\u20132.8), after adjusting for age, race\/ethnicity, and LSIL Pap result. Private insurance was associated with decreased time to colposcopy in unadjusted, but not multivariate analysis. Drug use was not associated with time to follow-up colposcopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Almost one third of HIV-infected women did not have a follow-up colposcopy by 12 months after an abnormal Pap test. Since HIV-infected women are at particularly high risk for cervical cancer, these results are unacceptably poor. Identification of the barriers to appropriate follow-up and targeted interventions are necessary to improve timely follow-up for cytologic abnormalities in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2011.3046","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T10:33:46Z","timestamp":1323081226000},"page":"418-424","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors Associated with Time to Colposcopy After Abnormal Pap Testing in HIV-Infected Women"],"prefix":"10.1177","volume":"21","author":[{"given":"Amy S.","family":"Baranoski","sequence":"first","affiliation":[{"name":"Boston University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stier","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2012,4,1]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"591","article-title":"Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears","volume":"4","author":"Wright TC","year":"1994","unstructured":"Wright TCJr, , Ellerbrock TV, , Chiasson MA, , Van Devanter N, , Sun XW. the New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol, 1994; 4:591\u2013597.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1031"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199809000-00013"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.111791"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181744619"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"S3\/63","DOI":"10.1016\/j.vaccine.2006.05.113","article-title":"Achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener HC","year":"2006","unstructured":"Kitchener HC, , Castle PE, , Cox JT. Achievements and limitations of cervical cytology screening. Vaccine, 2006; 24S3:S3\/63\u201370.","journal-title":"Vaccine"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.2006.00310.x"},{"key":"e_1_3_3_9_2","first-page":"123","article-title":"Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions","volume":"14","author":"Khanna N","year":"2000","unstructured":"Khanna N, , Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. J Am Board Fam Pract, 2000; 14:123\u2013130.","journal-title":"J Am Board Fam Pract"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.0161"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000159549.56601.75"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24851"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.10.046"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.8.2.129"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.8.6.510"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199911010-00005"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000266396.25244.68"},{"key":"e_1_3_3_18_2","first-page":"825","article-title":"Inadequate follow-up for abnormal Pap smears in an urban population","volume":"95","author":"Peterson NB","year":"2003","unstructured":"Peterson NB, , Han J, , Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc, 2003; 95:825\u2013832.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00176-R"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199803000-00015"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181cec0b5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2005.06.003"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/phr\/116.6.608"},{"key":"e_1_3_3_24_2","first-page":"2120","article-title":"2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright TC","year":"2002","unstructured":"Wright TCJr, , Cox JT, , Massad LS, , Twiggs LB, , Wikinson EJ. 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA, 2002; 287:2120\u20132129.","journal-title":"JAMA"},{"key":"e_1_3_3_25_2","first-page":"46","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"197","author":"Wright TC","year":"2007","unstructured":"Wright TC, , Massad LS, , Dunton CJ, , Spitzer M, , Wilkinson EJ, , Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. Am J Obstet Gynecol, 2007; 197:46\u201355.","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2010.2465"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2011.3046","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2011.3046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2011.3046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:37:03Z","timestamp":1777657023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2011.3046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1089\/jwh.2011.3046"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2011.3046","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}